Abstract:Objective: Osteosarcoma is the most common malignancy in the skeletal system; studies showed an important role of miRNAs in tumorigenesis, indicating miRNAs as possible therapeutic molecules. This study found abnormal hsa-miR-557 expression levels in osteosarcoma and tried to explore the potential function and the mechanism. Methods: Differential expression genes of osteosarcoma were analyzed using GSE28423 from the GEO database. Survival analysis of miRNAs was conducted with data obtained from the TARGET-OS database. STRING and miRDIP were used to predict target genes of hsa-miR-557; KRAS was then verified using dual-luciferase reporter assay. Expression of genes was detected by qPCR, and levels of proteins were detected by Western blot. The proliferation ability of cells was detected by CCK-8 and cell cycle analysis. Tumor formation assay in nude mice was used to detect the influence of osteosarcoma by hsa-miR-557 in vivo. Results: Analysis from the GEO and TARGET databases found 12 miRNAs that are significantly related to the osteosarcoma prognosis, 7 downregulated (hsa-miR-140-3p, hsa-miR-564, hsa-miR-765, hsa-miR-1224-5p, hsa-miR-95, hsa-miR-940, and hsa-miR-557) and 5 upregulated (hsa-miR-362-3p, hsa-miR-149, hsa-miR-96, hsa-miR-744, and hsa-miR-769-5p). CCK-8 analysis and cell cycle analysis found that hsa-miR-557 could significantly inhibit the proliferation of osteosarcoma cells. The tumor formation assay in nude mice showed that tumor sizes and weights were inhibited by hsa-miR-557 transfection. Further studies also proved that hsa-miR-557 could target the 3'UTR of KRAS and modulate phosphorylation of downstream proteins. Conclusion: This study showed that hsa-miR-557 could inhibit osteosarcoma growth both in vivo and in vitro, by modulating KRAS expression.

RNAi-mediated Silencing of AQP1 Expression Inhibited the Proliferation, Invasion and Tumorigenesis of Osteosarcoma Cells

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Silencing of Glucose Transporter Protein-1 by Rna Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in Vivo

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

Sirna-Mediated Silencing of FOXQ1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Human Osteosarcoma Cells

Aquaporin 1 Promotes the Proliferation and Migration of Lung Cancer Cell in Vitro.

Silencing of Aurora Kinase A by RNA Interference Inhibits Tumor Growth in Human Osteosarcoma Cells by Inducing Apoptosis and G2/M Cell Cycle Arrest

Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.

Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.

Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.

Silencing XIAP Suppresses Osteosarcoma Cell Growth, and Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin and Cisplatin.

Knockdown of WWP1 Inhibits Growth and Invasion, but Induces Apoptosis of Osteosarcoma Cells.

Aquaporin1 Expression in Glioma Patients and Its Potential Func-Tion in Glioma Progression

MicroRNA-212 Suppresses the Proliferation and Migration of Osteosarcoma Cells by Targeting Forkhead Box Protein A1

Silencing of Aquaporinï¿½5 Inhibits the Growth of A549 Lung Cancer Cells in Vitro and in Vivo

Small Interfering RNA-mediated Silencing of G-protein-coupled Receptor 137 Inhibits Growth of Osteosarcoma Cells

Down-regulation of S100A9 Inhibits Osteosarcoma Cell Growth Through Inactivating MAPK and NF-κB Signaling Pathways

RNA Interference-Mediated Silencing of Aquaporin (AQP)-5 Hinders Angiogenesis of Colorectal Tumor by Suppressing the Production of Vascular Endothelial Growth Factor

Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.

DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo